Clinical Oncology

High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group

• OS Nielsen
• P Dombernowsky
• T Tursz

Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome

• G Ferrandina
• G Scambia
• S Mancuso

Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy

• SL Parsons
• SA Watson
• RJC Steele

Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence

• T Jahkola
• T Toivonen
• C Blomqvist

A feasibility study of roquinimex (Linomide) and alpha interferon in patients with advanced malignant melanoma or renal carcinoma

• MJ Mackean
• D Kerr
• J Cassidy

Radiobiological prediction of normal tissue toxicities and tumour response in the radiotherapy of advanced non-small-cell lung cancer

• JM Singer
• P Price
• RG Dale

Expression of a truncated form of hHb1 hair keratin in human breast carcinomas

• CH Régnier
• A Boulay
• MC Rio

Do patients with advanced breast cancer benefit from chemotherapy?

• AJ Ramirez
• KE Towlson
• RD Rubens

Diagnostic value of tissue polypeptide-specific antigen (TPS) in neuroblastoma and Wilms' tumour

• W Rebhandl
• B Rami
• E Horcher

Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience

• A Llombart-Cussac
• X Pivot
• A Le Cesne

Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation

• R Emig
• A Magener
• HP Sinn

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials

• K Aabo
• M Adams
• BY Yeap

Chromosome 5 allelic losses are early events in tumours of the papilla of Vater and occur at sites similar to those of gastric cancer

• A Achille
• A Baron
• A Scarpa

First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence

• J Sandercock
• MKB Parmar
• V Torri

A phase II study of bryostatin 1 in metastatic malignant melanoma

• DJ Propper
• V Macaulay
• AL Harris

Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer

• MI Saunders
• A Rojas
• N Verma

Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer

• MAS Chapman
• D Buckley
• NC Armitage

Absence of somatic alterations of the EB1 gene adenomatous polyposis coli-associated protein in human sporadic colorectal cancers

• P Jaïs
• J-C Sabourin
• B Bressac-de Paillerets

Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction

• A Castells
• L Boix
• JM Piqué

Lung cancer -- management and outcome in Glasgow, 1991--92

• E Kesson
• CE Bucknall
• CR Gillis